Olanzapine/Samidorphan Effects on Weight Gain
The Journal of Clinical Psychiatry · 2025
DOI: 10.4088/jcp.24m15526 ↗Kurz gefasst
Metaanalyse in der Zeitschrift The Journal of Clinical Psychiatry, 2025. Verfasst von Christoph U Correll und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Zucker Hillside Hospital, Glen Oaks, New York. Hauptthemen laut MEDLINE: Olanzapine, Weight Gain, Schizophrenia, Naltrexone. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Zucker Hillside Hospital, Glen Oaks, New York.
- Department of Psychiatry and Molecular Medicine Hempstead, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York.
- Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany.
- Department of Health Economics and Outcomes Research, Alkermes, Inc., Waltham, Massachusetts.
- Corresponding Author: Michael J. Doane, PhD, Health Economics and Outcomes Research (HEOR), Alkermes, Inc., 900 Winter Street, Waltham, MA 02451-1420 (michael.doane@alkermes.com).
- Department of Neuroscience, Alkermes Pharma Ireland Ltd., Dublin, Ireland.
Zitieren
APA
Correll, C. U., Doane, M. J., McDonnell, D., Akerman, S., & Saklad, S. R. (2025). Olanzapine/Samidorphan Effects on Weight Gain. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.24m15526
Vancouver
Correll CU, Doane MJ, McDonnell D, Akerman S, Saklad SR. Olanzapine/Samidorphan Effects on Weight Gain. The Journal of Clinical Psychiatry. 2025. doi:10.4088/jcp.24m15526
BibTeX
@article{Correll2025,
author = {Correll, Christoph U and Doane, Michael J and McDonnell, David and Akerman, Sarah and Saklad, Stephen R},
title = {Olanzapine/Samidorphan Effects on Weight Gain},
journal = {The Journal of Clinical Psychiatry},
year = {2025},
doi = {10.4088/jcp.24m15526}
}
EUVIMED